{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T11:44:29Z","timestamp":1786275869482,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05769-w","type":"journal-article","created":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T11:36:32Z","timestamp":1786275392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced in vitro anticancer activity of a platinum\u2013Mesalazine complex against colorectal cancer cells apoptotic modulation and evidence of non-intercalative DNA binding"],"prefix":"10.1007","author":[{"given":"Kimiya","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2118-6142","authenticated-orcid":false,"given":"Abdolreza","family":"Sabokrouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahare","family":"Noohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrokh","family":"Modarresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,9]]},"reference":[{"issue":"8","key":"5769_CR1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28496.PMID:36185861;PMCID:PMC9514374","volume":"14","author":"A Abaza","year":"2022","unstructured":"Abaza A, Vasavada AM, Sadhu A, Valencia C, Fatima H, Nwankwo I, Anam M, Maharjan S, Amjad Z, Khan S (2022) A systematic review of apoptosis in correlation with cancer: should apoptosis be the ultimate target for cancer treatment? Cureus 14(8):e28496. https:\/\/doi.org\/10.7759\/cureus.28496.PMID:36185861;PMCID:PMC9514374","journal-title":"Cureus"},{"issue":"Suppl 2","key":"5769_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1046\/j.1365-2036.18.s2.1.x","volume":"18","author":"H Allgayer","year":"2003","unstructured":"Allgayer H (2003) Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Aliment Pharmacol Ther 18(Suppl 2):10\u201314. https:\/\/doi.org\/10.1046\/j.1365-2036.18.s2.1.x.\u00a0","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"5769_CR3","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.14309\/ajg.0000000000000669","volume":"115","author":"U Ali Khan","year":"2020","unstructured":"Ali Khan U, Fallah M, Tian Y, Sundquist K, Sundquist J, Brenner H, Kharazmi E (2020) Personal history of diabetes as important as family history of colorectal cancer for risk of colorectal cancer: a nationwide cohort study. Am J Gastroenterol 115(7):1103\u20131109. https:\/\/doi.org\/10.14309\/ajg.0000000000000669.\u00a0","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"5769_CR4","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1111\/j.1572-0241.2000.03360.x","volume":"95","author":"H Bantel","year":"2000","unstructured":"Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K (2000D) Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol 95(12):3452\u20133457. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.03360.x.\u00a0","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"5769_CR5","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s10552-014-0470-7","volume":"25","author":"T Boyle","year":"2014","unstructured":"Boyle T, Fritschi L, Tabatabaei SM, Ringwald K, Heyworth JS (2014) Smoking, alcohol, diabetes, obesity, socioeconomic status, and the risk of colorectal cancer in a population-based case-control study. Cancer Causes Control 25(12):1659\u201368. https:\/\/doi.org\/10.1007\/s10552-014-0470-7","journal-title":"Cancer Causes Control"},{"issue":"11","key":"5769_CR6","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.3390\/ijms25116188.PMID:38892375;PMCID:PMC11172443","volume":"25","author":"AM Burgos-Molina","year":"2024","unstructured":"Burgos-Molina AM, T\u00e9llez Santana T, Redondo M, Bravo Romero MJ (2024) The crucial role of inflammation and the immune system in colorectal cancer carcinogenesis: a comprehensive perspective. Int J Mol Sci 25(11):6188. https:\/\/doi.org\/10.3390\/ijms25116188.PMID:38892375;PMCID:PMC11172443","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5769_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12943-024-02101-z.PMID:39242496;PMCID:PMC11378508","volume":"23","author":"YT Chan","year":"2024","unstructured":"Chan YT, Zhang C, Wu J, Lu P, Xu L, Yuan H, Feng Y, Chen ZS, Wang N (2024) Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Mol Cancer 23(1):189. https:\/\/doi.org\/10.1186\/s12943-024-02101-z.PMID:39242496;PMCID:PMC11378508","journal-title":"Mol Cancer"},{"key":"5769_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364\u2013378. https:\/\/doi.org\/10.1016\/j.ejphar.2014.07.025","journal-title":"Eur J Pharmacol"},{"key":"5769_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0022-2836(81)90357-0","volume":"149","author":"RE Dickerson","year":"1981","unstructured":"Dickerson RE, Drew HR (1981) Structure of a B-DNA 964 dodecamer. J Mol Biol 149:761\u2013786\nhttps:\/\/rcsb.orghttp:\/\/www.accelrys.com","journal-title":"J Mol Biol"},{"key":"5769_CR10","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1073\/pnas.78.4.2179","volume":"78","author":"HR Drew","year":"1981","unstructured":"Drew HR et al (1981) Structure of a B-DNA dodecamer: conformation and dynamics. Proc Natl Acad Sci U S A 78:2179\u20132183","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"5769_CR11","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","volume":"77","author":"S Dilruba","year":"2016","unstructured":"Dilruba S, Kalayda GV (2016) Platinum-based drugs: past, present and future. Cancer Chemother Pharmacol 77(6):1103\u20131124. https:\/\/doi.org\/10.1007\/s00280-016-2976-z","journal-title":"Cancer Chemother Pharmacol"},{"issue":"9","key":"5769_CR12","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.5306\/wjco.v15.i9.1136.PMID:39351451;PMCID:PMC11438855","volume":"15","author":"H Fadlallah","year":"2024","unstructured":"Fadlallah H, El Masri J, Fakhereddine H, Youssef J, Chemaly C, Doughan S, Abou-Kheir W (2024) Colorectal cancer: recent advances in management and treatment. World J Clin Oncol 15(9):1136\u20131156. https:\/\/doi.org\/10.5306\/wjco.v15.i9.1136.PMID:39351451;PMCID:PMC11438855","journal-title":"World J Clin Oncol"},{"key":"5769_CR13","unstructured":"Frisch MJ et al (2013) Gaussian 09, Revision D.01. Gaussian, Inc., Wallingford CT"},{"issue":"2","key":"5769_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1055\/s-0043-1761420.PMID:38322607;PMCID:PMC10843885","volume":"37","author":"A Feria","year":"2023","unstructured":"Feria A, Times M (2023) Effectiveness of standard treatment for stage 4 colorectal cancer: traditional management with surgery, radiation, and chemotherapy. Clin Colon Rectal Surg 37(2):62\u201365. https:\/\/doi.org\/10.1055\/s-0043-1761420.PMID:38322607;PMCID:PMC10843885","journal-title":"Clin Colon Rectal Surg"},{"issue":"15","key":"5769_CR15","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I, Michels J et al (2012) Molecular mechanisms of cisplatin resistance. Oncogene 31(15):1869\u201383. https:\/\/doi.org\/10.1038\/onc.2011.384","journal-title":"Oncogene"},{"key":"5769_CR16","unstructured":"Goosenberg E, Kaur A, Babiker HM (2025) A review of hereditary colorectal cancers In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing"},{"issue":"1","key":"5769_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9.PMID:38433280;PMCID:PMC10910037","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, Zeng C, Zhou T, Zhang J (2024) NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther 9(1):53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9.PMID:38433280;PMCID:PMC10910037","journal-title":"Signal Transduct Target Ther"},{"key":"5769_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jinorgbio.2013.07.034","volume":"127","author":"W Hu","year":"2013","unstructured":"Hu W, Deng S, Huang J, Lu Y, Le X, Zheng W (2013) Intercalative interaction of asymmetric copper(II) complex with DNA: experimental, molecular docking, molecular dynamics and TDDFT studies. J Inorg Biochem 127:90\u201398. https:\/\/doi.org\/10.1016\/j.jinorgbio.2013.07.034","journal-title":"J Inorg Biochem"},{"key":"5769_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD - visual molecular dynamics. J Mol Graph 14:33\u201338","journal-title":"J Mol Graph"},{"key":"5769_CR20","doi-asserted-by":"publisher","unstructured":"Jabbari N, Sabokrouh A (2025) Enhanced anticancer efficacy of aluminum-curcumin complex compared to curcumin in colorectal cancer cells. Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 5. https:\/\/doi.org\/10.1007\/s00210-025-03836-2.\u00a0","DOI":"10.1007\/s00210-025-03836-2"},{"issue":"7","key":"5769_CR21","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41416-019-0721-1","volume":"122","author":"E Laconi","year":"2020","unstructured":"Laconi E, Marongiu F, DeGregori J (2020) Cancer as a disease of old age: changing mutational and microenvironmental landscapes. Br J Cancer 122(7):943\u2013952. https:\/\/doi.org\/10.1038\/s41416-019-0721-1","journal-title":"Br J Cancer"},{"issue":"3","key":"5769_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/carcin\/bgr306","volume":"33","author":"J Munding","year":"2012","unstructured":"Munding J, Ziebarth W, Pox CP, Ladigan S et al (2012) The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the \u03b2-catenin signaling pathway. Carcinogenesis 33(3):637\u201343. https:\/\/doi.org\/10.1093\/carcin\/bgr306","journal-title":"Carcinogenesis"},{"key":"5769_CR23","unstructured":"Nakashima J, Patel P, Preuss CV (2025) Mesalamine (USAN) [Updated 2024 Feb 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551714"},{"key":"5769_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-32617-3","volume":"16","author":"B Noohi","year":"2026","unstructured":"Noohi B, Zahedi M (2026) Impact of spatial lesion symmetry on the structural response of hydroxylated B-DNA. Sci Rep 16:2886. https:\/\/doi.org\/10.1038\/s41598-025-32617-3","journal-title":"Sci Rep"},{"issue":"4","key":"5769_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/ph11040101.PMID:30314310;PMCID:PMC6316056","volume":"11","author":"A Pannunzio","year":"2018","unstructured":"Pannunzio A, Coluccia M (2018) Cyclooxygenase-1 (COX-1) and COX-1 inhibitors in cancer: a review of oncology and medicinal chemistry literature. Pharmaceuticals (Basel) 11(4):101. https:\/\/doi.org\/10.3390\/ph11040101.PMID:30314310;PMCID:PMC6316056","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"5769_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1039\/c0ib00144a","volume":"3","author":"J Plati","year":"2011","unstructured":"Plati J, Bucur O, Khosravi-Far R (2011) Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb) 3(4):279\u201396. https:\/\/doi.org\/10.1039\/c0ib00144a","journal-title":"Integr Biol (Camb)"},{"key":"5769_CR27","doi-asserted-by":"publisher","unstructured":"Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D'Orazi G (2016) Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY).8(4):603\u201319. https:\/\/doi.org\/10.18632\/aging.100934.\u00a0","DOI":"10.18632\/aging.100934"},{"issue":"3","key":"5769_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s40495-017-0088-z","volume":"3","author":"NJW Rattray","year":"2017","unstructured":"Rattray NJW, Charkoftaki G, Rattray Z, Hansen JE, Vasiliou V, Johnson CH (2017) Environmental influences in the etiology of colorectal cancer: the premise of metabolomics. Curr Pharmacol Rep 3(3):114\u2013125. https:\/\/doi.org\/10.1007\/s40495-017-0088-z","journal-title":"Curr Pharmacol Rep"},{"issue":"7","key":"5769_CR29","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1021\/tx100170p.PMID:20578739;PMCID:PMC2930193","volume":"23","author":"L Rao","year":"2010","unstructured":"Rao L, West TK, Saluta G, Kucera GL (2010Jul 19) Bierbach U (2010) Probing platinum-adenine-n3 adduct formation with DNA minor-groove binding agents. Chem Res Toxicol 23(7):1148\u20131150. https:\/\/doi.org\/10.1021\/tx100170p.PMID:20578739;PMCID:PMC2930193","journal-title":"Chem Res Toxicol"},{"key":"5769_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jphotobiol.2013.08.005","volume":"128","author":"N Shahabadi","year":"2013","unstructured":"Shahabadi N, Fili SM, Kheirdoosh F (2013) Study on the interaction of the drug mesalamine with calf thymus DNA using molecular docking and spectroscopic techniques. J Photochem Photobiol B 128:20\u201326. https:\/\/doi.org\/10.1016\/j.jphotobiol.2013.08.005","journal-title":"J Photochem Photobiol B"},{"key":"5769_CR31","doi-asserted-by":"publisher","unstructured":"Strubberg AM, Madison BB (2017) MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications. Dis Model Mech 1;10(3):197\u2013214.https:\/\/doi.org\/10.1242\/dmm.027441.\u00a0","DOI":"10.1242\/dmm.027441"},{"issue":"6","key":"5769_CR32","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1007\/s00210-023-02841-7","volume":"397","author":"A Sabokrouh","year":"2024","unstructured":"Sabokrouh A, Hajivand S, Atabi F (2024) Comparison of anti-cancer effects of platinum ribavirin and ribavirin via telomerase and Bcl-2 gene expression. Naunyn Schmiedebergs Arch Pharmacol 397(6):3907\u20133915. https:\/\/doi.org\/10.1007\/s00210-023-02841-7","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"13","key":"5769_CR33","doi-asserted-by":"publisher","first-page":"5081","DOI":"10.3390\/molecules28135081.PMID:37446747;PMCID:PMC10343926","volume":"28","author":"J S\u0142oka","year":"2023","unstructured":"S\u0142oka J, Madej M, Strzalka-Mrozik B (2023) Molecular mechanisms of the antitumor effects of mesalazine and its preventive potential in colorectal cancer. Molecules 28(13):5081. https:\/\/doi.org\/10.3390\/molecules28135081.PMID:37446747;PMCID:PMC10343926","journal-title":"Molecules"},{"issue":"1","key":"5769_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/15257770.2016.1218021","volume":"36","author":"N Shahabadi","year":"2017","unstructured":"Shahabadi N, Falsafi M, Maghsudi M (2017) DNA-binding study of anticancer drug cytarabine by spectroscopic and molecular docking techniques. Nucleosides Nucleotides Nucleic Acids 36(1):49\u201365. https:\/\/doi.org\/10.1080\/15257770.2016.1218021","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"726","key":"5769_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.144132","volume":"5","author":"A Soleimani","year":"2020","unstructured":"Soleimani A, Rahmani F, Ferns GA, Ryzhikov M, Avan A, Hassanian SM (2020) Role of the NF-\u03baB signaling pathway in the pathogenesis of colorectal cancer. Gene 5(726):144132. https:\/\/doi.org\/10.1016\/j.gene.2019.144132.\u00a0","journal-title":"Gene"},{"key":"5769_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/525794","author":"N Shahabadi","year":"2011","unstructured":"Shahabadi N, Kashanian S, Mahdavi M, Sourinejad N (2011) DNA interaction and DNA cleavage studies of a new platinum(II) complex containing aliphatic and aromatic dinitrogen ligands. Bioinorg Chem Appl. https:\/\/doi.org\/10.1155\/2011\/525794","journal-title":"Bioinorg Chem Appl"},{"issue":"1","key":"5769_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00384-024-04748-y.PMID:39465427;PMCID:PMC11513726","volume":"39","author":"VK Shahgoli","year":"2024","unstructured":"Shahgoli VK, Noorolyai S, Ahmadpour Youshanlui M, Saeidi H, Nasiri H, Mansoori B, Holmskov U (2024Oct 28) Baradaran B (2024) Inflammatory bowel disease, colitis, and cancer: unmasking the chronic inflammation link. Int J Colorectal Dis 39(1):173. https:\/\/doi.org\/10.1007\/s00384-024-04748-y.PMID:39465427;PMCID:PMC11513726","journal-title":"Int J Colorectal Dis"},{"issue":"18","key":"5769_CR38","doi-asserted-by":"publisher","first-page":"8200","DOI":"10.1093\/nar\/gkr491","volume":"39","author":"B Wu","year":"2011","unstructured":"Wu B, Davey GE, Nazarov AA, Dyson PJ, Davey CA (2011) Specific DNA structural attributes modulate platinum anticancer drug site selection and cross-link generation. Nucleic Acids Res 39(18):8200\u20138212. https:\/\/doi.org\/10.1093\/nar\/gkr491","journal-title":"Nucleic Acids Res"},{"key":"5769_CR39","doi-asserted-by":"publisher","unstructured":"Wang H (2020) MicroRNAs and apoptosis in colorectal cancer. Int J Mol Sci 28;21(15):5353. https:\/\/doi.org\/10.3390\/ijms21155353.\u00a0","DOI":"10.3390\/ijms21155353"},{"key":"5769_CR40","doi-asserted-by":"publisher","unstructured":"Yang Y, Weaver MN, Merz KM Jr (2009) Assessment of the \u201c6-31+G** + LANL2DZ\u201d mixed basis set coupled with density functional theory methods and the effective core potential: prediction of heats of formation and ionization potentials for first-row-transition-metal complexes. J Phys Chem A 113(36):9843\u201351. https:\/\/doi.org\/10.1021\/jp807643p","DOI":"10.1021\/jp807643p"},{"issue":"6","key":"5769_CR41","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1080\/07391102.2018.1461137","volume":"37","author":"S Zhang","year":"2019","unstructured":"Zhang S, Yang H, Zhao L, Gan R, Tang P, Sun Q, Xiong X, Li H (2019) Capecitabine as a minor groove binder of DNA: molecular docking, molecular dynamics, and multi-spectroscopic studies. J Biomol Struct Dyn 37(6):1451\u20131463. https:\/\/doi.org\/10.1080\/07391102.2018.1461137","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"5769_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2.PMID:38763973;PMCID:PMC11102923","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y, Tian X, Guan X, Cen X, Zhao Y (2024) Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduct Target Ther 9(1):132. https:\/\/doi.org\/10.1038\/s41392-024-01823-2.PMID:38763973;PMCID:PMC11102923","journal-title":"Signal Transduct Target Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05769-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05769-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05769-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T11:36:33Z","timestamp":1786275393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05769-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,9]]},"references-count":42,"alternative-id":["5769"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05769-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,9]]},"assertion":[{"value":"6 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and ethically approved and granted by the Department of Biochemistry and Biophysics, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants are informed and consented the project.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The names of participants were not published.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}